Lay health workers used phone calls to assess symptoms on a weekly basis for high-risk patients and on a monthly basis for low-risk patients.
Previous findings showed a 7 month median overall survival benefit (P = .002) for patients with lung cancer given web-mediated follow-up.
The researchers also developed novel emoji PRO scales and associations between PROs and wearable data.
Researchers assigned 38 patients with metastatic renal cell carcinoma to receive pegilodecakin plus nivolumab or pembrolizumab.
The impact of this attenuated-dose hypomethylating agents among patients with low-risk myelodysplastic syndrome who are transfusion independent requires further investigation.
Although progression-free survival was not significantly increased, long-term overall survival may be improved with pertuzumab.
The efficacy of nelarabine among newly diagnosed patients with T-cell ALL has not been fully explored.
Current literature reflects estimates, but not actual rates, of low-dose computed tomography adherence across the United States.
Investigators sought to determine whether cognitive behavioral therapy or acupuncture was more effective in addressing insomnia in this population.
The CYCORE system may enable physicians to intervene at the early signs of dehydration and other radiotherapy-associated symptoms.
